07:00 , Apr 14, 2000 |  BC Extra  |  Financial News

Valentis raises $19.2 million

Gene therapy company VLTS sold 1.915 million shares at $10.00 per share in a private placement. Investors included the State of Wisconsin Investment Board; BayStar Capital; Merlin BioMed Asset Management; Framlington Asset Management; Park Place...